デフォルト表紙
市場調査レポート
商品コード
980091

生物製剤の世界市場:2030年までの機会と戦略 - COVID-19の影響と回復

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 391 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.49円
生物製剤の世界市場:2030年までの機会と戦略 - COVID-19の影響と回復
出版日: 2020年12月28日
発行: The Business Research Company
ページ情報: 英文 391 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の生物製剤市場について調査しており、市場規模や予測、動向や戦略、成長および抑制要因、COVID-19の影響、タイプ・投与経路・購入モード・医薬品分類・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

  • 地域別セグメンテーション
  • タイプ別セグメンテーション
    • モノクローナル抗体(MAbS)
    • 治療用タンパク質
    • ワクチン
  • 投与経路別セグメンテーション
  • 購入モード別セグメンテーション
  • 流通チャネル別セグメンテーション

第7章 生物製剤市場の特徴

  • 市場の定義
  • タイプ別セグメンテーション
    • 治療用タンパク質
    • モノクローナル抗体((MAbS)
    • ワクチン
  • 投与経路別セグメンテーション
    • 経口
    • その他(IVおよびIP)
  • 医薬品分類別セグメンテーション
    • ブランド薬
    • ジェネリック医薬品
  • 購入モード別セグメンテーション
    • 処方薬
    • 店頭(OTC)薬
  • 流通チャネル別セグメンテーション
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 生物製剤市場、サプライチェーン分析

  • 原材料サプライヤー
  • 研究開発
    • 臨床研究
    • 受託調査機関(CRO)
    • 承認
  • 生物製剤製造
    • 契約製造組織(CMO)
  • 流通
    • 卸売業者/流通業者
    • 小売業者
    • 利用者

第9章 製品分析-製品例

第10章 市場の顧客情報

  • バイオシミラーおよび生物製剤に対する患者の認識
  • バイオシミラーの採用に関する認識
  • 生物学的製剤よりもバイオシミラーに対する患者の選好み
  • 副作用の少ないインフルエンザワクチンの選好
  • 副作用による予防接種ワクチンに対する患者の躊躇

第11章 市場の動向と戦略

  • 生物製剤の医薬品開発を促進するために改訂されたFDA規制
  • 生物製剤のより高い利益率
  • 小分子から生物製剤への移行
  • 堅牢な研究開発
  • 複雑な病気の治療における生物製剤の需要

第12章 生物製剤市場に対するCovid-19の影響

  • 研究開発資金への影響
  • サプライチェーンへの影響
  • 回復

第13章 世界の生物製剤市場の規模と成長

  • 市場規模
  • 市場成長:売上実績(2015-2019)
    • 市場成長要因
    • 市場抑制要因
  • 市場成長:売上予測(2019-2023、2025F、2030F)

第14章 生物製剤市場、地域分析

  • 市場売上実績と予測(2015-2019、2023、2025、2030)
  • 市場実績と予測(2015-2023)
  • 市場成長とシェアの比較(2019-2023)

第15章 世界市場セグメンテーション

  • タイプ別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • モノクローナル抗体
    • 治療用タンパク質
    • ワクチン
    • モノクローナル抗体(MAbS)タイプ別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • 抗がんMAbS
    • 免疫学的MAbS
    • 抗感染性モノクローナル抗体(MAbS)
    • 心血管および脳血管MAbS
    • 神経薬理学的MABS
    • その他-モノクローナル抗体(MAb)
    • 治療用タンパク質タイプ別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • 代謝障害治療タンパク質
    • がん治療タンパク質
    • 心血管治療タンパク質
    • 免疫学的治療タンパク質
    • その他-治療用タンパク質
    • ワクチンタイプ別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • 抗感染症ワクチン
    • 自己免疫ワクチン
    • その他-ワクチン
  • 投与経路別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • 経口
    • その他
  • 医薬品分類別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • ブランド薬
    • ジェネリック医薬品
  • 購入モード別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • 処方薬
    • OTC薬
  • 流通チャネル別セグメンテーション:売上実績および予測(2015-2019、2023F、2025F、2030F)
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第16章 マクロ経済要因と世界の生物製剤市場の比較

  • 生物製剤の市場規模、GDPの割合
  • 一人当たりの平均生物製剤市場支出

第17章 アジア太平洋生物製剤市場

第18章 西欧の生物製剤市場

第19章 東欧の生物製剤市場

第20章 北米の生物製剤市場

第21章 南米の生物製剤市場

第22章 中東の生物製剤市場

第23章 アフリカの生物製剤市場

第24章 競合情勢

  • 企業プロファイル
  • Pfizer Inc.
  • F. Hoffmann-La Roche AG
  • AbbVie Inc.
  • Merck & Co., Inc., Inc.
  • Johnson & Johnson

第25章 主要合併と買収

第26章 市場の背景:医薬品市場

  • 医薬品市場の特徴
    • 市場の定義
    • タイプ別セグメンテーション
  • タイプ別売上(2015-2023)
  • 地域別売上(2019)
  • 地域別実績と予測(2015-2023)

第27章 生物製剤市場の機会と戦略

  • 2023年の市場:最も新しい機会を提供する国
  • 2023年の市場:最も新しい機会を提供するセグメント
  • 2023年の市場:成長戦略
    • 市場動向ベースの戦略
    • 競合の戦略

第28章 生物製剤市場、結論・提言

  • 結論
  • 提言

第29章 付録

目次

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the biologics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global biologics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by distribution channel, by route of administration, by drug classification, and by mode of purchase.

Market Characteristics - The market characteristics section of the report defines and explains the biologics market. This chapter includes different products and services covered in the report and basic definitions.

Supply Chain - The supply chain section of the report defines and explains the key players in the biologics market supply chain.

Product Analysis - The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.

Customer Information- This chapters covers recent customers' trends/preferences in the global biologics market.

Trends And Strategies - This chapter describes the major trends shaping the global biologics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 - This section describes the impact of COVID-19 on the biologics market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.

Market Segmentation - This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.

Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).

Competitive Landscape - This section covers details on the competitive landscape of the global biologics market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for biologics companies in terms of product offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global biologics market is segmented into -

By Type: Therapeutic Proteins; Monoclonal Antibodies ((MAbS); Vaccines

Therapeutic Proteins are further segmented into- Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins

Monoclonal Antibodies (MAbS) are further segmented into- Anti-Cancer MABS; Immunological MABS; Anti-Infective Monoclonal Antibodies (MABS); Neuropharmacological Mabs; Cardiovascular And Cerebrovascular MABS; Others - Monoclonal Antibodies (MABS)

Vaccines are further segmented into- Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

By Route Of Administration: Oral; Others (IV and IP)

By Drug Classification: Branded Drugs; Generic Drugs

By Mode Of Purchase: Prescription Drugs; Over-The-Counter (OTC) Drugs

By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Merck & Co., Inc.; Johnson & Johnson

Countries: China, Australia, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Biologics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Biologics Market Segmentation By Type
    • 6.2.1. Monoclonal Antibodies (MAbS) Segmentation By Type
    • 6.2.2. Therapeutic Proteins Segmentation By Type
    • 6.2.3. Vaccines Segmentation By Type
  • 6.3. Biologics Market Segmentation By Route Of Administration
  • 6.4. Biologics Market Segmentation By Mode Of Purchase
  • 6.5. Biologics Market Segmentation By Distribution Channel

7. Biologics Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Type
    • 7.2.1. Therapeutic Proteins
    • 7.2.2. Monoclonal Antibodies ((MAbS)
    • 7.2.3. Vaccines
  • 7.3. Market Segmentation By Route Of Administration
    • 7.3.1. Oral
    • 7.3.2. Others (IV and IP)
  • 7.4. Market Segmentation By Drug Classification
    • 7.4.1. Branded Drugs
    • 7.4.2. Generic Drugs
  • 7.5. Market Segmentation By Mode Of Purchase
    • 7.5.1. Prescription Drugs
    • 7.5.2. Over-The-Counter (OTC) Drugs
  • 7.6. Market Segmentation By Distribution Channel
    • 7.6.1. Hospital Pharmacies
    • 7.6.2. Retail Pharmacies
    • 7.6.3. Online Pharmacies

8. Biologics Market, Supply Chain Analysis

  • 8.1. Raw Material Suppliers
  • 8.2. Research and Development
    • 8.2.1. Clinical Studies
    • 8.2.2. Contract Research Organization (CRO)
    • 8.2.3. Approval
  • 8.3. Biologics Manufacturing
    • 8.3.1. Contract Manufacturing Organization (CMO)
  • 8.4. Distribution
    • 8.4.1. Wholesalers/Distributors
    • 8.4.2. Retailers
    • 8.4.3. End Users

9. Biologics Market Product Analysis - Product Examples

10. Biologics Market Customer Information

  • 10.1. Awareness Of The Patients For Biosimilars And Biologics
  • 10.2. Perception On The Adoption Of Biosimilars
  • 10.3. Patients' Preference For Biosimilar Over Biologics
  • 10.4. Preference For Influenza Vaccines With Fewer Side Effects
  • 10.5. Hesitance Of Patients Towards Immunization Vaccines Due To Its Side Effects

11. Biologics Market Trends And Strategies

  • 11.1. Revised FDA Regulations To Facilitate Biologics Drug Development
  • 11.2. Higher Profit Margins For Biologics
  • 11.3. Shift From Small Molecules To Biologics
  • 11.4. Robust Research & Development
  • 11.5. Demand For Biologics In The Treatment Of Complex Diseases

12. Impact Of Covid-19 On Biologics Market

  • 12.1. Impact On R&D Funding
  • 12.2. Impact On Supply Chain
  • 12.3. Recovery

13. Global Biologics Market Size And Growth

  • 13.1. Market Size
  • 13.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 13.2.1. Drivers Of The Market 2015 - 2019
    • 13.2.2. Restraints On The Market 2015-19
  • 13.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 13.3.1. Drivers Of The Market 2019 - 2023
    • 13.3.2. Restraints On The Market 2019-2023

14. Biologics Market, Regional Analysis

  • 14.1. Global Biologics Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.2. Global Biologics Market, 2015 - 2023, Historic And Forecast, By Region
  • 14.3. Global Biologics Market, 2019-2023, Growth And Market Share Comparison, By Region

15. Global Biologics Market Segmentation

  • 15.1. Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.1. Monoclonal Antibodies
    • 15.1.2. Therapeutic Proteins
    • 15.1.3. Vaccines
    • 15.1.4. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.5. Anti-Cancer MAbS
    • 15.1.6. Immunological MAbS
    • 15.1.7. Anti-Infective Monoclonal Antibodies (MAbS)
    • 15.1.8. Cardiovascular And Cerebrovascular MAbS
    • 15.1.9. Neuropharmacological MABS
    • 15.1.10. Others - Monoclonal Antibodies (MAbs)
    • 15.1.11. Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.12. Metabolic Disorders Therapeutic Proteins
    • 15.1.13. Cancer Therapeutic Proteins
    • 15.1.14. Cardiovascular Therapeutic Proteins
    • 15.1.15. Immunological Therapeutic Proteins
    • 15.1.16. Others - Therapeutic Proteins
    • 15.1.17. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.18. Anti-Infective Vaccines
    • 15.1.19. Autoimmunity Vaccines
    • 15.1.20. Others-Vaccines
  • 15.2. Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.2.1. Oral
    • 15.2.2. Others
  • 15.3. Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.3.1. Branded Drugs
    • 15.3.2. Generic Drugs
  • 15.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.4.1. Prescription Drugs
    • 15.4.2. OTC Drugs
  • 15.5. Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies

16. Global Biologics Market Comparison with Macro Economic Factors

  • 16.1. Biologics Market Size, Percentage Of GDP, Global
  • 16.2. Per Capita Average Biologics Market Expenditure, Global

17. Asia-Pacific Biologics Market

  • 17.1. Asia-Pacific Biologics Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Impact Of COVID-19
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. Asia-Pacific Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. Asia-Pacific Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million)
  • 17.6. Asia-Pacific Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 17.7. Asia-Pacific Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 17.8. Asia-Pacific Biologics Market Metrics
    • 17.8.1. Per Capita Biologics Expenditure, 2019, Asia-Pacific Major Countries
    • 17.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
    • 17.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
  • 17.9. Asia-Pacific Biologics Market: Country Analysis
  • 17.10. Australia Biologics Market
  • 17.11. Australia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.12. Australia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.13. Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.14. China Biologics Market
  • 17.15. China Biologics Market Overview
    • 17.15.1. Country Information
    • 17.15.2. Market Information
    • 17.15.3. Impact Of COVID-19
    • 17.15.4. Background Information
    • 17.15.5. Government Initiatives
    • 17.15.6. Regulations
    • 17.15.7. Regulatory Bodies
    • 17.15.8. Major Associations
    • 17.15.9. Taxes Levied
    • 17.15.10. Corporate Tax Structure
    • 17.15.11. Investments
    • 17.15.12. Major Companies
  • 17.16. China Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.17. China Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.18. China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.19. Hong Kong Biologics Market
  • 17.20. Hong Kong Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.21. Hong Kong Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.22. India Biologics Market
  • 17.23. India Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.24. India Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.25. India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.26. Indonesia Biologics Market
  • 17.27. Indonesia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.28. Indonesia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.29. Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.30. Japan Biologics Market
  • 17.31. Japan Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.32. Japan Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.33. Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.34. Malaysia Biologics Market
  • 17.35. Malaysia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.36. Malaysia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.37. New Zealand Biologics Market
  • 17.38. New Zealand Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.39. New Zealand Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.40. Philippines Biologics Market
  • 17.41. Philippines Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.42. Philippines Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.43. Singapore Biologics Market
  • 17.44. Singapore Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.45. Singapore Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.46. South Korea Biologics Market
  • 17.47. South Korea Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.48. South Korea Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.49. South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.50. Thailand Biologics Market
  • 17.51. Thailand Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.52. Thailand Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.53. Vietnam Biologics Market
  • 17.54. Vietnam Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.55. Vietnam Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

18. Western Europe Biologics Market

  • 18.1. Western Europe Biologics Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. COVID Impact
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Western Europe Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.3. Western Europe Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.4. Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.5. Western Europe Biologics Market, 2019, By Country, Value ($ Million)
  • 18.6. Western Europe Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 18.7. Western Europe Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 18.8. Western Europe Biologics Market Metrics
    • 18.8.1. Per Capita Biologics Expenditure, 2019, Western Europe Major Countries
    • 18.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
    • 18.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
  • 18.9. Western Europe Biologics Market: Country Analysis
  • 18.10. Austria Biologics Market
  • 18.11. Austria Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.12. Austria Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.13. Belgium Biologics Market
  • 18.14. Belgium Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.15. Belgium Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.16. Denmark Biologics Market
  • 18.17. Denmark Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.18. Denmark Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.19. Finland Biologics Market
  • 18.20. Finland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.21. Finland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.22. France Biologics Market
  • 18.23. France Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.24. France Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.25. France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.26. Germany Biologics Market
  • 18.27. Germany Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.28. Germany Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.29. Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.30. Ireland Biologics Market
  • 18.31. Ireland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.32. Ireland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.33. Italy Biologics Market
  • 18.34. Italy Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.35. Italy Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.36. Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.37. Netherlands Biologics Market
  • 18.38. Netherlands Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.39. Netherlands Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.40. Norway Biologics Market
  • 18.41. Norway Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.42. Norway Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.43. Portugal Biologics Market
  • 18.44. Portugal Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.45. Portugal Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.46. Spain Biologics Market
  • 18.47. Spain Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.48. Spain Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.49. Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.50. Sweden Biologics Market
  • 18.51. Sweden Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.52. Sweden Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.53. Switzerland Biologics Market
  • 18.54. Switzerland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.55. Switzerland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.56. UK Biologics Market
  • 18.57. UK Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.58. UK Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.59. UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Eastern Europe Biologics Market

  • 19.1. Eastern Europe Biologics Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Major Associations
    • 19.1.8. Taxes Levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Eastern Europe Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.3. Eastern Europe Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.4. Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.5. Eastern Europe Biologics Market, 2019, By Country, Value ($ Million)
  • 19.6. Eastern Europe Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 19.7. Eastern Europe Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 19.8. Eastern Europe Biologics Market Metrics
    • 19.8.1. Per Capita Biologics Expenditure, 2019, Eastern Europe Major Countries
    • 19.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
    • 19.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
  • 19.9. Eastern Europe Biologics Market: Country Analysis
  • 19.10. Czech Republic Biologics Market
  • 19.11. Czech Republic Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.12. Czech Republic Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.13. Poland Biologics Market
  • 19.14. Poland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.15. Poland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.16. Romania Biologics Market
  • 19.17. Romania Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.18. Romania Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.19. Russia Biologics Market
  • 19.20. Russia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.21. Russia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.22. Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. North America Biologics Market

  • 20.1. North America Biologics Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Impact Of COVID-19
    • 20.1.4. Background Information
    • 20.1.5. Government Initiatives
    • 20.1.6. Regulations
    • 20.1.7. Regulatory Bodies
    • 20.1.8. Major Associations
    • 20.1.9. Taxes Levied
    • 20.1.10. Corporate Tax Structure
    • 20.1.11. Investment
    • 20.1.12. Major Companies
  • 20.2. North America Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.3. North America Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.4. North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.5. North America Biologics Market, 2019, By Country, Value ($ Million)
  • 20.6. North America Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 20.7. North America Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 20.8. North America Biologics Market Metrics
    • 20.8.1. Per Capita Biologics Expenditure, 2019, North America Major Countries
    • 20.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
    • 20.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
  • 20.9. North America Biologics Market: Country Analysis
  • 20.10. Canada Biologics Market
  • 20.11. Canada Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.12. Canada Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.13. Mexico Biologics Market
  • 20.14. Mexico Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.15. Mexico Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.16. USA Biologics Market
  • 20.17. USA Biologics Market Overview
    • 20.17.1. Country Information
    • 20.17.2. Market Information
    • 20.17.3. COVID Impact
    • 20.17.4. Background Information
    • 20.17.5. Government Initiatives
    • 20.17.6. Regulations
    • 20.17.7. Regulatory Bodies
    • 20.17.8. Major Associations
    • 20.17.9. Taxes Levied
    • 20.17.10. Corporate Tax Structure
    • 20.17.11. Investment
    • 20.17.12. Major Companies
  • 20.18. USA Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.19. USA Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.20. USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

21. South America Biologics Market

  • 21.1. South America Biologics Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. COVID Impact
    • 21.1.4. Background Information
    • 21.1.5. Government Initiatives
    • 21.1.6. Regulations
    • 21.1.7. Regulatory Bodies
    • 21.1.8. Major Associations
    • 21.1.9. Taxes Levied
    • 21.1.10. Corporate Tax Structure
    • 21.1.11. Investments
    • 21.1.12. Major Companies
  • 21.2. South America Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.3. South America Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.4. South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.5. South America Biologics Market, 2019, By Country, Value ($ Million)
  • 21.6. South America Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 21.7. South America Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 21.8. South America Biologics Market Metrics
    • 21.8.1. Per Capita Biologics Expenditure, 2019, South America Major Countries
    • 21.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
    • 21.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
  • 21.9. South America Biologics Market: Country Analysis
  • 21.10. Argentina Biologics Market
  • 21.11. Argentina Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.12. Argentina Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.13. Brazil Biologics Market
  • 21.14. Brazil Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.15. Brazil Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.16. Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.17. Chile Biologics Market
  • 21.18. Chile Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.19. Chile Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.20. Colombia Biologics Market
  • 21.21. Colombia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.22. Colombia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.23. Peru Biologics Market
  • 21.24. Peru Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.25. Peru Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.26. Venezuela Biologics Market
  • 21.27. Venezuela Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.28. Venezuela Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

22. Middle East Biologics Market

  • 22.1. Middle East Biologics Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Impact Of COVID-19
    • 22.1.4. Background Information
    • 22.1.5. Government Initiatives
    • 22.1.6. Regulations
    • 22.1.7. Regulatory Bodies
    • 22.1.8. Major Associations
    • 22.1.9. Taxes Levied
    • 22.1.10. Corporate Tax Structure
    • 22.1.11. Investments
    • 22.1.12. Major Companies
  • 22.2. Middle East Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.3. Middle East Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.4. Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.5. Middle East Biologics Market, 2019, By Country, Value ($ Million)
  • 22.6. Middle East Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 22.7. Middle East Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 22.8. Middle East Biologics Market Metrics
    • 22.8.1. Per Capita Biologics Expenditure, 2019, Middle East Major Countries
    • 22.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
    • 22.8.3. Of the featured countries, Turkey had the lowest average revenue per enterprise in the biologics market with $ 1,681,534. As of 2019, there were 276 biologics enterprises in Turkey. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
  • 22.9. Middle East Biologics Market: Country Analysis
  • 22.10. Israel Biologics Market
  • 22.11. Israel Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.12. Israel Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.13. Saudi Arabia Biologics Market
  • 22.14. Saudi Arabia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.15. Saudi Arabia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.16. Turkey Biologics Market
  • 22.17. Turkey Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.18. Turkey Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.19. UAE Biologics Market
  • 22.20. UAE Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.21. UAE Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

23. Africa Biologics Market

  • 23.1. Africa Biologics Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Impact Of COVID-19
    • 23.1.4. Background Information
    • 23.1.5. Government Initiatives
    • 23.1.6. Regulations
    • 23.1.7. Regulatory Bodies
    • 23.1.8. Major Associations
    • 23.1.9. Taxes Levied
    • 23.1.10. Corporate Tax Structure
    • 23.1.11. Investments
    • 23.1.12. Major Companies
  • 23.2. Africa Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.3. Africa Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.4. Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.5. Africa Biologics Market, 2019, By Country, Value ($ Million)
  • 23.6. Africa Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 23.7. Africa Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 23.8. Africa Biologics Market Metrics
    • 23.8.1. Per Capita Biologics Expenditure, 2019, Africa Major Countries
    • 23.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
    • 23.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
  • 23.9. Africa Biologics Market: Country Analysis
  • 23.10. Egypt Biologics Market
  • 23.11. Egypt Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.12. Egypt Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.13. Nigeria Biologics Market
  • 23.14. Nigeria Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.15. Nigeria Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.16. South Africa Biologics Market
  • 23.17. South Africa Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.18. South Africa Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

24. Global Biologics Market Competitive Landscape

  • 24.1. Company Profiles
  • 24.2. Pfizer Inc.
    • 24.2.1. Company Overview
    • 24.2.2. Products And Services
    • 24.2.3. Business Strategy
    • 24.2.4. Financial Overview
  • 24.3. F. Hoffmann-La Roche AG
    • 24.3.1. Company Overview
    • 24.3.2. Products And Services
    • 24.3.3. Business Strategy
    • 24.3.4. Financial Overview
  • 24.4. AbbVie Inc.
    • 24.4.1. Company Overview
    • 24.4.2. Products And Services
    • 24.4.3. Business Strategy
    • 24.4.4. Financial Overview
  • 24.5. Merck & Co., Inc., Inc.
    • 24.5.1. Company Overview
    • 24.5.2. Products And Services
    • 24.5.3. Business Strategy
    • 24.5.4. Financial Overview
  • 24.6. Johnson & Johnson
    • 24.6.1. Company Overview
    • 24.6.2. Products And Services
    • 24.6.3. Business Strategy
    • 24.6.4. Financial Overview

25. Key Mergers And Acquisitions In The Biologics Market

  • 25.1. Abbvie Acquired Allergan
  • 25.2. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer
  • 25.3. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.
  • 25.4. True North Acquired Stake In Biocon Biologics
  • 25.5. Catalent, Inc. Acquired Bristol Myers Squibb's Oral Dose Manufacturing Facility
  • 25.6. Bristol Myers Acquired Celgene
  • 25.7. Evotec Acquired Just Biotherapeutics
  • 25.8. AstraZeneca Strikes Stock Deal With Daiichi Sankyo
  • 25.9. Boehringer Acquires Rights To ICD Therapeutics And Its Biologics-Delivery Platform
  • 25.10. Catalent, Inc. Acquired Cook Pharmica LLC
  • 25.11. ADMA Biologics Acquired Biotest's Therapy Business
  • 25.12. Eagle Pharmaceuticals Acquired Arsia Therapeutics
  • 25.13. Takeda Acquired Baxalta's Manufacturing Facility

26. Market Background: Pharmaceuticals Market

  • 26.1. Pharmaceuticals Market Characteristics
    • 26.1.1. Market Definition
    • 26.1.2. Segmentation By Type
  • 26.2. Global Pharmaceuticals Market, Segmentation By Type, 2015 - 2023, Value ($ Billion)
  • 26.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
  • 26.4. Global Pharmaceuticals Market, 2015 - 2023, Historic And Forecast, By Region

27. Biologics Market Opportunities And Strategies

  • 27.1. Global Biologics Market In 2023 - Countries Offering Most New Opportunities
  • 27.2. Global Biologics Market In 2023 - Segments Offering Most New Opportunities
  • 27.3. Global Biologics Market In 2023 - Growth Strategies
    • 27.3.1. Market Trend Based Strategies
    • 27.3.2. Competitor Strategies

28. Biologics Market, Conclusions And Recommendations

  • 28.1. Conclusions
  • 28.2. Recommendations
    • 28.2.1. Product
    • 28.2.2. Place
    • 28.2.3. Price
    • 28.2.4. Promotion
    • 28.2.5. People

29. Appendix

  • 29.1. Market Data Sources
  • 29.2. Research Methodology
  • 29.3. Currencies
  • 29.4. Research Inquiries
  • 29.5. The Business Research Company
  • 29.6. Copyright and Disclaimer